Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An eight-week, double-blind, group sequential design, placebo controlled trial to evaluate the safety and efficacy of the co-administration of sertraline and elzasonan (CP-448,187) in outpatients with major depressive disorder https://kusajili.com:443/Trial/zWa7UmLYK0Ghvw_fGNl3Dw%24an-eight-week-double-blind-group-sequential-design-placebo-controlled-trial-to-evaluate-the-safety-and-efficacy-of-the-co-admin
I have read and accept the terms of use of the site and the Privacy Policy
Send your message